From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves Namzaric to treat Alzheimer's disease

from Pharmacy Times

The FDA has approved Namzaric, a fixed-dose combination of memantine hydrochloride extended-release, an N-methyl D-aspartate receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063